Obstetrics & Gynecology Doctors in Centennial, CO Accepting Medicare

9 Obstetrics & Gynecology doctors found. Showing 1 - 9

Barbara J Thompson, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-850-2074

Dr. Myda Thi Luu, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545

Dr. Simon D Payne, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545

Dr. Alexandra Marcotty, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545

Dr. Cynthia J Celnik, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545

Dr. Jill J Ingenito, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545

Dr. Zachary Thomas Ripp, M.D Obstetrics & Gynecology - Obstetrics Medicare: Medicare Enrolled Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545

Dr. Arielle Risa Gumer, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545

Dr. Kevin James Heinze, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 14000 E Arapahoe Rd, Suite 390, Centennial, CO 80112 Phone: 303-632-3600    Fax: 303-632-3606

News Archive

Indoor exposure to radon gas may cause of lung cancer

Pointing to startling statistics on lung cancer risks, child health and other experts in Canada are ramping up calls for families nationwide to test their homes for radon gas contamination.

Ghana's community-based surveillance is enabling early detection of preventable diseases

Members of the public trained on how to collect health information in Ghana are enabling early detection and reporting of vaccine-preventable diseases such as measles, a study says.

Schering-Plough receives FDA recommendation approval for PEGINTRON

Schering-Plough Corp. announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON® (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma.

Merge Healthcare signs distribution agreement with PANGAEA Technology

Merge Healthcare, a leading medical imaging solutions provider, today announced that its Merge China business unit has signed a Distribution Agreement with PANGAEA Technology Limited, a distributor of CCD detectors, which are an economical alternative to digital detectors, for DR systems in the Greater China area.

Project to study the generation and movement of harmful algal blooms

NOAA and the National Science Foundation have awarded $824,225 in competitive funds for the first year of an anticipated four-year $2.8 million project to develop early warning forecast models for toxic harmful algal blooms, or HABs, on Pacific Northwest beaches. Funds were awarded to the University of Washington and the University of California at Santa Cruz through the interagency Ecology and Oceanography of Harmful Algal Blooms (ECOHAB) program.

Read more Medical News

› Verified 6 days ago